(Total Views: 275)
Posted On: 01/24/2020 6:52:17 PM
Post# of 1354
CBDNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Significant New Order, Expects Several More for Revolutionary Nanoemulsification System for Water-Soluble CBD Oil
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer for six proprietary Ultra Shear Technology(TM) (“UST”)-based nanoemulsification systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. According to the update, such nanoemulsions are expected to exhibit bioavailability levels that far exceed those of today's macro or microemulsions of CBD oil. “In addition to the new order for six BaroShear K45 systems, there are numerous additional groups who have shown high levels of interest in acquiring the new BaroShear K45 nanoemulsification system,” PBIO President and CEO Richard T. Schumacher said in the news release. “Our team is diligently following up with these interested parties; we believe that several of these groups will be placing purchase orders with us in the very near future. These are very exciting times for all PBIO stakeholders.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new customer for six proprietary Ultra Shear Technology(TM) (“UST”)-based nanoemulsification systems for processing CBD oil into stable, effectively water-soluble, highly absorbable nanoemulsions of oil in water. According to the update, such nanoemulsions are expected to exhibit bioavailability levels that far exceed those of today's macro or microemulsions of CBD oil. “In addition to the new order for six BaroShear K45 systems, there are numerous additional groups who have shown high levels of interest in acquiring the new BaroShear K45 nanoemulsification system,” PBIO President and CEO Richard T. Schumacher said in the news release. “Our team is diligently following up with these interested parties; we believe that several of these groups will be placing purchase orders with us in the very near future. These are very exciting times for all PBIO stakeholders.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
